Literature DB >> 28947644

Why Antibiotic Treatment Is Not Enough for Sepsis Resolution: an Evaluation in an Experimental Animal Model.

Jonathan L Halbach1, Andrew W Wang1, Dennis Hawisher2, David M Cauvi2, Radhames E Lizardo1, Joseph Rosas3, Tony Reyes3, Omar Escobedo3, Stephen W Bickler2,4, Raul Coimbra2, Antonio De Maio5,3,6.   

Abstract

Sepsis remains a major health problem at the levels of mortality, morbidity, and economic burden to the health care system, a condition that is aggravated by the development of secondary conditions such as septic shock and multiple-organ failure. Our current understanding of the etiology of human sepsis has advanced, at least in part, due to the use of experimental animal models, particularly the model of cecum ligation and puncture (CLP). Antibiotic treatment has been commonly used in this model to closely mirror the treatment of human septic patients. However, whether their use may obscure the elucidation of the cellular and molecular mechanisms involved in the septic response is questionable. The objective of the present study was to determine the effect of antibiotic treatment in the outcome of a fulminant model of CLP. Various dosing strategies were used for the administration of imipenem, which has broad-spectrum coverage of enteric bacteria. No statistically significant differences in the survival of mice were observed between the different antibiotic dosing strategies and no treatment, suggesting that live bacteria may not be the only factor inducing septic shock. To further investigate this hypothesis, mice were challenged with sterilized or unsterilized cecal contents. We found that exposure of mice to sterilized cecal contents also resulted in a high mortality rate. Therefore, it is possible that bacterial debris, apart from bacterial proliferation, triggers a septic response and contributes to mortality in this model, suggesting that additional factors are involved in the development of septic shock.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  antibiotics; cecal ligation and puncture; infection; inflammation; sepsis

Mesh:

Substances:

Year:  2017        PMID: 28947644      PMCID: PMC5695106          DOI: 10.1128/IAI.00664-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Prospective external validation of the clinical effectiveness of an emergency department-based early goal-directed therapy protocol for severe sepsis and septic shock.

Authors:  Alan E Jones; Anne Focht; James M Horton; Jeffrey A Kline
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

2.  Hypertonic saline resuscitation limits neutrophil activation after trauma-hemorrhagic shock.

Authors:  Edwin A Deitch; Han Ping Shi; Eleonora Feketeova; Carl J Hauser; Da-Zhong Xu
Journal:  Shock       Date:  2003-04       Impact factor: 3.454

3.  Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis.

Authors:  N Zantl; A Uebe; B Neumann; H Wagner; J R Siewert; B Holzmann; C D Heidecke; K Pfeffer
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

4.  Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality.

Authors:  H Bryant Nguyen; Stephen W Corbett; Robert Steele; Jim Banta; Robin T Clark; Sean R Hayes; Jeremy Edwards; Thomas W Cho; William A Wittlake
Journal:  Crit Care Med       Date:  2007-04       Impact factor: 7.598

5.  Period of irreversible therapeutic intervention during sepsis correlates with phase of innate immune dysfunction.

Authors:  David M Cauvi; Donghuan Song; Daniel E Vazquez; Dennis Hawisher; Jose A Bermudez; Michael R Williams; Stephen Bickler; Raul Coimbra; Antonio De Maio
Journal:  J Biol Chem       Date:  2012-04-19       Impact factor: 5.157

6.  The sepsis seesaw: tilting toward immunosuppression.

Authors:  Richard S Hotchkiss; Craig M Coopersmith; Jonathan E McDunn; Thomas A Ferguson
Journal:  Nat Med       Date:  2009-05       Impact factor: 53.440

7.  Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.

Authors:  Rosa C S Vianna; Rachel N Gomes; Fernando A Bozza; Rodrigo T Amâncio; Patrícia T Bozza; Cid M N David; Hugo C Castro-Faria-Neto
Journal:  Shock       Date:  2004-02       Impact factor: 3.454

8.  Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department.

Authors:  David F Gaieski; Mark E Mikkelsen; Roger A Band; Jesse M Pines; Richard Massone; Frances F Furia; Frances S Shofer; Munish Goyal
Journal:  Crit Care Med       Date:  2010-04       Impact factor: 7.598

Review 9.  Resistance mechanisms.

Authors:  Yasemin Cag; Hulya Caskurlu; Yanyan Fan; Bin Cao; Haluk Vahaboglu
Journal:  Ann Transl Med       Date:  2016-09

10.  Shorter Duration of Post-Operative Antibiotics for Cecal Ligation and Puncture Does Not Increase Inflammation or Mortality.

Authors:  Kendra N Iskander; Max Vaickus; Elizabeth R Duffy; Daniel G Remick
Journal:  PLoS One       Date:  2016-09-26       Impact factor: 3.240

View more
  14 in total

1.  Reply to "Bacterial Proliferation May Be the Key Component of Sepsis Mortality".

Authors:  Antonio De Maio
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

2.  Bacterial Proliferation May Be the Key Component of Sepsis Mortality.

Authors:  Christian de Tymowski; Mario D T Correia; Renato C Monteiro; Philippe Montravers; Sanae Ben Mkaddem
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

3.  Regulation of the Nfkbiz Gene and Its Protein Product IkBζ in Animal Models of Sepsis and Endotoxic Shock.

Authors:  Arturo Casas; Dennis Hawisher; Christian B De Guzman; Stephen W Bickler; Antonio De Maio; David M Cauvi
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

Review 4.  Can the Cecal Ligation and Puncture Model Be Repurposed To Better Inform Therapy in Human Sepsis?

Authors:  John C Alverdy; Robert Keskey; Renee Thewissen
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

5.  Early hyperbaric oxygen therapy improves survival in a model of severe sepsis.

Authors:  Jonathan L Halbach; James M Prieto; Andrew W Wang; Dennis Hawisher; David M Cauvi; Tony Reyes; Jonathan Okerblom; Israel Ramirez-Sanchez; Francisco Villarreal; Hemal H Patel; Stephen W Bickler; George A Perdrizet; Antonio De Maio
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-15       Impact factor: 3.619

6.  Cargo-less nanoparticles program innate immune cell responses to toll-like receptor activation.

Authors:  Liam M Casey; Sandeep Kakade; Joseph T Decker; Justin A Rose; Kyle Deans; Lonnie D Shea; Ryan M Pearson
Journal:  Biomaterials       Date:  2019-07-04       Impact factor: 12.479

7.  The Contribution of the Omentum to the Outcome From Sepsis: An Experimental Animal Study.

Authors:  Andrew W Wang; David M Cauvi; Dennis Hawisher; Tony Reyes; Raul Coimbra; Stephen Bickler; Antonio De Maio
Journal:  Shock       Date:  2019-12       Impact factor: 3.454

Review 8.  Nanoplatforms for Sepsis Management: Rapid Detection/Warning, Pathogen Elimination and Restoring Immune Homeostasis.

Authors:  Gan Luo; Jue Zhang; Yaqi Sun; Ya Wang; Hanbin Wang; Baoli Cheng; Qiang Shu; Xiangming Fang
Journal:  Nanomicro Lett       Date:  2021-03-08

9.  A nanotrap improves survival in severe sepsis by attenuating hyperinflammation.

Authors:  Changying Shi; Xiaojing Wang; Lili Wang; Qinghe Meng; Dandan Guo; Li Chen; Matthew Dai; Guirong Wang; Robert Cooney; Juntao Luo
Journal:  Nat Commun       Date:  2020-07-07       Impact factor: 14.919

10.  Inducing Experimental Polymicrobial Sepsis by Cecal Ligation and Puncture.

Authors:  Frances V Sjaastad; Isaac J Jensen; Roger R Berton; Vladimir P Badovinac; Thomas S Griffith
Journal:  Curr Protoc Immunol       Date:  2020-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.